4//SEC Filing
Durham Mark Andrew 4
Accession 0000885590-11-000025
CIK 0000885590other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 1:48 PM ET
Size
8.6 KB
Accession
0000885590-11-000025
Insider Transaction Report
Form 4
Durham Mark Andrew
SVP, Human Resources
Transactions
- Exercise/Conversion
Common Stock, no par value
2011-05-11$24.50/sh+50,000$1,225,000→ 111,595 total - Sale
Common Stock, no par value
2011-05-11$52.17/sh−50,000$2,608,500→ 61,595 total - Exercise/Conversion
Stock Options (right to purchase)
2011-05-11−50,000→ 0 totalExercise: $24.50From: 2009-03-01Exp: 2011-05-25→ Common Stock, no par value (50,000 underlying)
Footnotes (1)
- [F1]The reporting person is exercising stock options that were set to expire on May 25, 2011 if unexercised.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001477126
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 1:48 PM ET
- Size
- 8.6 KB